share_log

Truist Securities Maintains Buy on Merck & Co, Raises Price Target to $143

Benzinga ·  Apr 26 11:52

Truist Securities analyst Robyn Karnauskas maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $142 to $143.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment